|
ITFG2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.65700000000535E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.636400E-04 |
| Normal-vs-Stage2 |
1.709400E-01 |
| Normal-vs-Stage3 |
1.939679999996E-05 |
| Normal-vs-Stage4 |
5.22290000026793E-07 |
| Stage1-vs-Stage2 |
9.960500E-02 |
| Stage1-vs-Stage3 |
9.485900E-02 |
| Stage1-vs-Stage4 |
1.441610E-02 |
| Stage2-vs-Stage3 |
1.121560E-02 |
| Stage2-vs-Stage4 |
2.184900E-03 |
| Stage3-vs-Stage4 |
4.145600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.55450000000257E-05 |
| Normal-vs-AfricanAmerican |
5.564400E-02 |
| Normal-vs-Asian |
5.224200E-03 |
| Caucasian-vs-AfricanAmerican |
3.585200E-01 |
| Caucasian-vs-Asian |
1.742430E-01 |
| AfricanAmerican-vs-Asian |
8.875600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.056680E-03 |
| Normal-vs-Female |
5.91650000000277E-05 |
| Male-vs-Female |
5.801800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.393900E-04 |
| Normal-vs-Age(41-60Yrs) |
6.045200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.176820E-04 |
| Normal-vs-Age(81-100Yrs) |
1.021190E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.879600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.803400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.228160E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.106800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.542300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.049250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.67996000000059E-05 |
| Classical-VS-Follicular |
1.861880E-03 |
| Classical-VS-Other |
9.378400E-01 |
| Classical-VS-Normal |
3.51120000000593E-05 |
| Tall-VS-Follicular |
6.06179995088496E-09 |
| Tall-VS-Other |
2.226300E-02 |
| Tall-VS-Normal |
4.96930052662492E-10 |
| Follicular-VS-Other |
3.475600E-01 |
| Follicular-VS-Normal |
2.880000E-01 |
| Other-VS-Normal |
8.866400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.517700E-03 |
| Normal-vs-N1 |
2.91859999945743E-07 |
| N0-vs-N1 |
3.342000E-03 |
|
|
